PMC:7205724 / 468-669
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
11 | 31-39 | Disease | denotes | COVID-19 | MESH:C000657245 |
17 | 65-68 | Gene | denotes | IL6 | Gene:3569 |
18 | 124-127 | Gene | denotes | IL6 | Gene:3569 |
19 | 92-100 | Species | denotes | patients | Tax:9606 |
20 | 44-55 | Chemical | denotes | Tocilizumab | MESH:C502936 |
21 | 106-114 | Disease | denotes | COVID-19 | MESH:C000657245 |
53 | 143-160 | Species | denotes | novel coronavirus | Tax:2697049 |
54 | 162-171 | Species | denotes | SARS-CoV2 | Tax:2697049 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T4 | 31-39 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 106-114 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 162-166 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 183-184 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T2 | 2-12 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | viral load | http://purl.bioontology.org/ontology/MEDDRA/10062178 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T4 | 31-39 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T5 | 106-114 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T6 | 162-171 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 41-128 | Sentence | denotes | • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6. |
T10 | 130-138 | Sentence | denotes | Abstract |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
11 | 31-39 | Disease | denotes | COVID-19 | MESH:C000657245 |
20 | 44-55 | Chemical | denotes | Tocilizumab | MESH:C502936 |
17 | 65-68 | Gene | denotes | IL6 | Gene:3569 |
19 | 92-100 | Species | denotes | patients | Tax:9606 |
21 | 106-114 | Disease | denotes | COVID-19 | MESH:C000657245 |
18 | 124-127 | Gene | denotes | IL6 | Gene:3569 |
53 | 143-160 | Species | denotes | novel coronavirus | Tax:2697049 |
54 | 162-171 | Species | denotes | SARS-CoV2 | Tax:2697049 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T45 | 65-68 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
T89 | 124-127 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67 | 0-1 | -COMMA- | denotes | , |
T68 | 2-7 | JJ | denotes | viral |
T69 | 8-12 | NN | denotes | load |
T70 | 12-13 | -COMMA- | denotes | , |
T71 | 14-17 | CC | denotes | and |
T72 | 18-27 | NN | denotes | prognosis |
T73 | 28-30 | IN | denotes | of |
T74 | 31-39 | NN | denotes | COVID-19 |
T75 | 41-42 | IN | denotes | • |
T76 | 44-55 | NNP | denotes | Tocilizumab |
T77 | 55-56 | -COMMA- | denotes | , |
T78 | 57-59 | DT | denotes | an |
T79 | 60-68 | NN | denotes | anti-IL6 |
T80 | 68-69 | -COMMA- | denotes | , |
T81 | 70-73 | MD | denotes | can |
T82 | 74-80 | VB | denotes | confer |
T83 | 81-88 | NN | denotes | benefit |
T84 | 89-91 | IN | denotes | in |
T85 | 92-100 | NNS | denotes | patients |
T86 | 101-105 | IN | denotes | with |
T87 | 106-114 | NN | denotes | COVID-19 |
T88 | 115-118 | CC | denotes | and |
T89 | 119-123 | JJ | denotes | high |
T90 | 124-127 | NN | denotes | IL6 |
T91 | 130-138 | NN | denotes | Abstract |
T92 | 139-142 | DT | denotes | The |
T93 | 143-148 | JJ | denotes | novel |
T94 | 149-160 | NN | denotes | coronavirus |
T95 | 160-161 | -COMMA- | denotes | , |
T96 | 162-171 | NN | denotes | SARS-CoV2 |
T97 | 171-172 | -COMMA- | denotes | , |
T98 | 173-176 | MD | denotes | can |
T99 | 177-182 | VB | denotes | cause |
T100 | 183-184 | DT | denotes | a |
T101 | 185-196 | RB | denotes | potentially |
R62 | T69 | T67 | arg2Of | load,"," |
R63 | T69 | T68 | arg1Of | load,viral |
R64 | T71 | T70 | arg1Of | and,"," |
R65 | T67 | T71 | arg1Of | ",",and |
R66 | T72 | T71 | arg2Of | prognosis,and |
R67 | T72 | T73 | arg1Of | prognosis,of |
R68 | T74 | T73 | arg2Of | COVID-19,of |
R69 | T82 | T75 | arg1Of | confer,• |
R70 | T76 | T77 | arg1Of | Tocilizumab,"," |
R71 | T79 | T77 | arg2Of | anti-IL6,"," |
R72 | T79 | T78 | arg1Of | anti-IL6,an |
R73 | T82 | T80 | arg1Of | confer,"," |
R74 | T76 | T81 | arg1Of | Tocilizumab,can |
R75 | T82 | T81 | arg2Of | confer,can |
R76 | T76 | T82 | arg1Of | Tocilizumab,confer |
R77 | T83 | T82 | arg2Of | benefit,confer |
R78 | T82 | T84 | arg1Of | confer,in |
R79 | T85 | T84 | arg2Of | patients,in |
R80 | T85 | T86 | arg1Of | patients,with |
R81 | T88 | T86 | arg2Of | and,with |
R82 | T87 | T88 | arg1Of | COVID-19,and |
R83 | T90 | T88 | arg2Of | IL6,and |
R84 | T90 | T89 | arg1Of | IL6,high |
R85 | T94 | T92 | arg1Of | coronavirus,The |
R86 | T94 | T93 | arg1Of | coronavirus,novel |
R87 | T94 | T95 | arg1Of | coronavirus,"," |
R88 | T96 | T95 | arg2Of | SARS-CoV2,"," |
R89 | T99 | T97 | arg1Of | cause,"," |
R90 | T94 | T98 | arg1Of | coronavirus,can |
R91 | T99 | T98 | arg2Of | cause,can |
R92 | T94 | T99 | arg1Of | coronavirus,cause |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T4 | 31-39 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 106-114 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 162-171 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 41-128 | Sentence | denotes | • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6. |
T10 | 130-138 | Sentence | denotes | Abstract |